These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8032828)

  • 21. Qualitative and quantitative histopathology in transitional cell carcinomas of the urinary bladder. An international investigation of intra- and interobserver reproducibility.
    Sørensen FB; Sasaki M; Fukuzawa S; Yamabe H; Olsen S; Yoshida O
    Lab Invest; 1994 Feb; 70(2):242-54. PubMed ID: 8139265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour front inflammation and necrosis are independent prognostic predictors in high-grade urothelial carcinoma of the bladder.
    Hodgson A; Xu B; Satkunasivam R; Downes MR
    J Clin Pathol; 2018 Feb; 71(2):154-160. PubMed ID: 28768702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Grading of superficial bladder cancer by quantitative mitotic frequency analysis.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
    J Urol; 1993 Jan; 149(1):36-41. PubMed ID: 8417213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors in nodular transitional cell bladder tumours.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H
    Scand J Urol Nephrol; 1993; 27(2):205-10. PubMed ID: 8351473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma.
    Cheng L; Neumann RM; Nehra A; Spotts BE; Weaver AL; Bostwick DG
    Cancer; 2000 Apr; 88(7):1663-70. PubMed ID: 10738225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.
    Soukup V; Čapoun O; Cohen D; Hernández V; Babjuk M; Burger M; Compérat E; Gontero P; Lam T; MacLennan S; Mostafid AH; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Yuan Y; Zigeuner R
    Eur Urol; 2017 Nov; 72(5):801-813. PubMed ID: 28457661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder.
    Raitanen MP; Nieminen P; Tammela TL
    Br J Urol; 1995 Oct; 76(4):470-4. PubMed ID: 7551884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 expression predicts progression and poor survival in T1 bladder tumours.
    Llopis J; Alcaraz A; Ribal MJ; Solé M; Ventura PJ; Barranco MA; Rodriguez A; Corral JM; Carretero P
    Eur Urol; 2000 Jun; 37(6):644-53. PubMed ID: 10828662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The significance of tumour grade in predicting disease progression in stage Ta transitional cell carcinoma of the urinary bladder.
    Chen SS; Chen KK; Lin AT; Chang YH; Wu HH; Hsu TH; Chang LS
    Br J Urol; 1996 Aug; 78(2):209-12. PubMed ID: 8813915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic correlation of morphometric values with survival in invasive transitional cell carcinoma of the bladder.
    Portillo JA; Val-Bernal JF; Garijo MF; Buelta L; Gutiérrez JL
    Br J Urol; 1992 Dec; 70(6):628-33. PubMed ID: 1486389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival and progression in high grade tumour subset of G2 and G3 pT1 bladder transitional cell carcinoma.
    Kamel MH; Daly PJ; Khan MF; Kay EW; O'Kelly P; Hickey DP
    Eur J Surg Oncol; 2006 Dec; 32(10):1139-43. PubMed ID: 16784833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of morphometry and DNA flow cytometry with standard prognostic factors in bladder cancer.
    Lipponen PK; Collan Y; Eskelinen MJ; Pesonen E; Sotarauta M; Nordling S
    Br J Urol; 1990 Jun; 65(6):589-97. PubMed ID: 2372672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear morphometry in grading transitional cell bladder cancer compared with subjective histological grading.
    Lipponen P; Eskelinen M
    Anticancer Res; 1990; 10(6):1725-30. PubMed ID: 2285249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility and prognostic value of WHO1973 and WHO2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder.
    Mangrud OM; Waalen R; Gudlaugsson E; Dalen I; Tasdemir I; Janssen EA; Baak JP
    PLoS One; 2014; 9(1):e83192. PubMed ID: 24409280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical prognostic factors in superficial cancer of the urinary bladder].
    Busto Catañón L; Sánchez Merino JM; Picallo Sánchez JA; Gelabert Mas A
    Arch Esp Urol; 2001 Mar; 54(2):131-8. PubMed ID: 11341116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of histopathological grading and immunoreactivity for p53 and p21/WAF1 in grade 2 pTa transitional cell carcinoma of the urinary bladder.
    Leissner J; Hohenfellner R; Thüroff JW; Köppen C; Wolf HK
    Eur Urol; 2001 Apr; 39(4):438-45. PubMed ID: 11306883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grading in superficial bladder cancer. (1). Morphological criteria.
    Pauwels RP; Schapers RF; Smeets AW; Debruyne FM; Geraedts JP
    Br J Urol; 1988 Feb; 61(2):129-34. PubMed ID: 3349277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urothelial tumours of the urinary bladder: a histopathological study of cystoscopic biopsies.
    Vaidya S; Lakhey M; K C S; Hirachand S
    JNMA J Nepal Med Assoc; 2013; 52(191):475-8. PubMed ID: 24907954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.
    Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A
    Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.